newsfilter
← Latest News
GlobeNewswire·

Xilio Therapeutics Announces Pricing of Underwritten Offering

WALTHAM, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer,